Before the Bell
$
1.24
Change
+0.03 +2.48%
Volume
Volume 27,150
Jun 27, 2022, 7:46 a.m.
Real time quotes
Previous close
$ 1.21
$ 1.21
Change
-0.02 -1.63%
Day low
Day high
$1.11
$1.35

52 week low
52 week high
$0.92
$4.17

Market cap
$106.87M
Average volume
839,649
P/E ratio
N/A
Rev. per Employee
$41,667
EPS
-0.48
Dividend
N/A
Div yield
N/A
Ex dividend date
N/A
MarketWatch News on LPTX
-
Leap Therapeutics started at buy with $6 stock price target at Mizuho
- Tomi Kilgore
-
Leap Therapeutics downgraded to market perform from outperform at Raymond James
- Tomi Kilgore
-
Leap Therapeutics stock price target cut to $8 from $13 at Raymond James
- Tomi Kilgore
-
Leap Therapeutics started at buy with $18 stock price target at Ladenburg Thalmann
- Tomi Kilgore
Analyst Ratings
-
Benzinga's Top Upgrades, Downgrades For March 7, 2017
- Benzinga.com
-
Benzinga's Top Upgrades, Downgrades For March 1, 2017
- Benzinga.com
Other News on LPTX
- Loading more headlines...
Press Releases on LPTX
-
Leap Therapeutics to Host Virtual R&D Day on July 12, 2022
- PR Newswire - PRF
-
Leap Therapeutics Reports First Quarter 2022 Financial Results
- PR Newswire - PRF
-
Leap Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results
- PR Newswire - PRF
-
Leap Therapeutics to Present at B. Riley Securities Oncology Investor Conference
- PR Newswire - PRF
-
Gastrointestinal Cancer Treatment Trials Driven by Rising Incidences of Colorectal Cancer
- Financial News Media
-
Leap Therapeutics to Present at H.C. Wainwright BioConnect 2022 Conference
- PR Newswire - PRF
-
Leap Therapeutics to Present at 40th Annual J.P. Morgan Healthcare Conference
- PR Newswire - PRF
-
Leap Therapeutics Reports Third Quarter 2021 Financial Results
- PR Newswire - PRF
- Loading more headlines...
Rates »
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com